Literature DB >> 35771219

Effects of home-based leg heat therapy on walking performance in patients with symptomatic peripheral artery disease: a pilot randomized trial.

Jacob C Monroe1, Byung Joon Pae1, Christopher Kargl1, Timothy P Gavin1, Jason Parker2, Susan M Perkins3, Yan Han3, Janet Klein4, Raghu L Motaganahalli4, Bruno T Roseguini1.   

Abstract

Few noninvasive therapies currently exist to improve functional capacity in people with lower extremity peripheral artery disease (PAD). The goal of the present study was to test the hypothesis that unsupervised, home-based leg heat therapy (HT) using water-circulating trousers perfused with warm water would improve walking performance in patients with PAD. Patients with symptomatic PAD were randomized into either leg HT (n = 18) or a sham treatment (n = 16). Patients were provided with water-circulating trousers and a portable pump and were asked to apply the therapy daily (7 days/wk, 90 min/session) for 8 wk. The primary study outcome was the change from baseline in 6-min walk distance at 8-wk follow-up. Secondary outcomes included the claudication onset-time, peak walking time, peak pulmonary oxygen consumption and peak blood pressure during a graded treadmill test, resting blood pressure, the ankle-brachial index, postocclusive reactive hyperemia in the calf, cutaneous microvascular reactivity, and perceived quality of life. Of the 34 participants randomized, 29 completed the 8-wk follow-up. The change in 6-min walk distance at the 8-wk follow-up was significantly higher (P = 0.029) in the group exposed to HT than in the sham-treated group (Sham: median: -0.9; 25%, 75% percentiles: -5.8, 14.3; HT: median: 21.3; 25%, 75% percentiles: 10.1, 42.4, P = 0.029). There were no significant differences in secondary outcomes between the HT and sham group at 8-wk follow-up. The results of this pilot study indicate that unsupervised, home-based leg HT is safe, well-tolerated, and elicits a clinically meaningful improvement in walking tolerance in patients with symptomatic PAD.NEW & NOTEWORTHY This is the first sham-controlled trial to examine the effects of home-based leg heat therapy (HT) on walking performance in patients with peripheral artery disease (PAD). We demonstrate that unsupervised HT using water-circulating trousers is safe, well-tolerated, and elicits meaningful changes in walking ability in patients with symptomatic PAD. This home-based treatment option is practical, painless, and may be a feasible adjunctive therapy to counteract the decline in lower extremity physical function in patients with PAD.

Entities:  

Keywords:  heat therapy; intermittent claudication; peripheral artery disease

Mesh:

Substances:

Year:  2022        PMID: 35771219      PMCID: PMC9448284          DOI: 10.1152/japplphysiol.00143.2022

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  67 in total

1.  Lower-limb hot-water immersion acutely induces beneficial hemodynamic and cardiovascular responses in peripheral arterial disease and healthy, elderly controls.

Authors:  Kate N Thomas; André M van Rij; Samuel J E Lucas; James D Cotter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-12-21       Impact factor: 3.619

Review 2.  Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association.

Authors:  Diane Treat-Jacobson; Mary M McDermott; Ulf G Bronas; Umberto Campia; Tracie C Collins; Michael H Criqui; Andrew W Gardner; William R Hiatt; Judith G Regensteiner; Kathleen Rich
Journal:  Circulation       Date:  2019-01-22       Impact factor: 29.690

Review 3.  The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease.

Authors:  William R Hiatt; R Kevin Rogers; Eric P Brass
Journal:  Circulation       Date:  2014-07-01       Impact factor: 29.690

Review 4.  Smoking and cardiovascular disease: mechanisms of endothelial dysfunction and early atherogenesis.

Authors:  Barbara Messner; David Bernhard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03       Impact factor: 8.311

5.  Repeated sauna therapy improves myocardial perfusion in patients with chronically occluded coronary artery-related ischemia.

Authors:  Mitsuo Sobajima; Takashi Nozawa; Hiroyuki Ihori; Takuya Shida; Takashi Ohori; Takayuki Suzuki; Akira Matsuki; Satoshi Yasumura; Hiroshi Inoue
Journal:  Int J Cardiol       Date:  2012-01-13       Impact factor: 4.164

6.  Serum from young, sedentary adults who underwent passive heat therapy improves endothelial cell angiogenesis via improved nitric oxide bioavailability.

Authors:  Vienna E Brunt; Karen M Weidenfeld-Needham; Lindan N Comrada; Michael A Francisco; Taylor M Eymann; Christopher T Minson
Journal:  Temperature (Austin)       Date:  2019-05-16

7.  Heat therapy improves soleus muscle force in a model of ischemia-induced muscle damage.

Authors:  Kyoungrae Kim; Blake A Reid; Bohyun Ro; Caitlin A Casey; Qifan Song; Shihuan Kuang; Bruno T Roseguini
Journal:  J Appl Physiol (1985)       Date:  2019-05-30

8.  Waon therapy upregulates Hsp90 and leads to angiogenesis through the Akt-endothelial nitric oxide synthase pathway in mouse hindlimb ischemia.

Authors:  Takahiro Miyauchi; Masaaki Miyata; Yoshiyuki Ikeda; Yuichi Akasaki; Narisato Hamada; Takahiro Shirasawa; Yuko Furusho; Chuwa Tei
Journal:  Circ J       Date:  2012-04-06       Impact factor: 2.993

9.  Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.

Authors:  Mary McGrae McDermott; Kiang Liu; Philip Greenland; Jack M Guralnik; Michael H Criqui; Cheeling Chan; William H Pearce; Joseph R Schneider; Luigi Ferrucci; Lillian Celic; Lloyd M Taylor; Ed Vonesh; Gary J Martin; Elizabeth Clark
Journal:  JAMA       Date:  2004-07-28       Impact factor: 56.272

10.  The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program.

Authors:  Judith G Regensteiner; William R Hiatt; Joseph R Coll; Michael H Criqui; Diane Treat-Jacobson; Mary M McDermott; Alan T Hirsch
Journal:  Vasc Med       Date:  2008-02       Impact factor: 3.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.